$ IVST Trading higher on News! StemVax Glioblast brain tumor vaccine. StemVax Now HAS the Exclusive Worldwide Rights to Four Key Technologies. https://globenewswire.com/news-release/2018/08/06/1547365/0/en/Innovest-Global-Signed-Agreement-with-Cedars-Sinai-Medical-Center-Provides-StemVax-the-Exclusive-Worldwide-Rights-to-Four-Key-Technologies.html @innovestglobal